ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ASHWANI SRIVASTAVA M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,912Medicare Part D Prescriptions Filled, Including Refills

Rank: 268 out of 2888

$726K Total Retail Price of All Prescriptions

Rank: 443 out of 2888

555 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

23% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,638 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 830 731 1 1
HYDROCODONE-ACETAMINOPHEN 466 379 S3 2 4
AMLODIPINE BESYLATE 458 397 3 5
LISINOPRIL 443 360 4 3
SIMVASTATIN 435 363 5 2
FUROSEMIDE 388 337 6 6
OMEPRAZOLE 344 315 7 7
CARVEDILOL 339 259 8 21
METFORMIN HCL 324 262 9 8
PRAVASTATIN SODIUM 260 227 10 12
METOPROLOL TARTRATE 258 220 11 10
HYDRALAZINE HCL 244 222 12 59
CLONIDINE HCL 228 182 13 39
NEXIUM 225 165 14 19
LOSARTAN POTASSIUM 215 179 15 18
GABAPENTIN 198 159 16 13
LOVASTATIN 196 176 17 41
CLOPIDOGREL 183 164 18 30
ALENDRONATE SODIUM 178 160 19 23
ALLOPURINOL 164 142 20 37
TRAMADOL HCL 161 111 21 16
ATORVASTATIN CALCIUM 154 133 22 9
AZITHROMYCIN 153 122 23 38
METOPROLOL SUCCINATE 152 121 24 11
POTASSIUM CHLORIDE 142 113 25 14
ZOLPIDEM TARTRATE 133 101 26 17
RANITIDINE HCL 131 126 27 56
WARFARIN SODIUM 128 117 28 22
PLAVIX 126 104 29 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 74 30 28
HYDROCHLOROTHIAZIDE 113 102 31 15
DIOVAN 112 99 32 35
CRESTOR 108 101 33 20
TRAZODONE HCL 106 84 34 43
GLYBURIDE 96 69 R 35 58
CITALOPRAM HBR 92 81 36 24
LOSARTAN-HYDROCHLOROTHIAZIDE 90 69 37 46
TAMSULOSIN HCL 89 84 38 29
MELOXICAM 85 76 39 31
PROAIR HFA 84 61 40 71
ATENOLOL 83 71 41 25
NIFEDIPINE ER 80 68 42 76
PANTOPRAZOLE SODIUM 77 62 43 33
INSULIN SYRINGE 76 63 44 86
NAMENDA 75 68 45 34
DONEPEZIL HCL 73 73 46 26
GLIMEPIRIDE 69 56 47 36
TERAZOSIN HCL 68 68 48 152
SYNTHROID 68 62 48 52
OXYBUTYNIN CHLORIDE 68 59 48 124
LANTUS 66 43 51 45
GEMFIBROZIL 65 50 52 98
FLUTICASONE PROPIONATE 64 47 53 32
CILOSTAZOL 63 63 54 165
PREDNISONE 62 54 55 42
DICLOFENAC SODIUM 60 48 56 141
CYCLOBENZAPRINE HCL 58 37 R 57 68
SERTRALINE HCL 58 42 57 27
DOXAZOSIN MESYLATE 56 49 59 94
CELEBREX 56 56 59 89
FINASTERIDE 55 54 61 102
ADVAIR DISKUS 54 38 62 60
VERAPAMIL ER 53 49 63 104
LEVOFLOXACIN 53 37 63 57
NOVOLIN 70-30 51 40 65 144
ENALAPRIL MALEATE 51 51 65 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.